ABCA3 and lung disorder: Thus, current therapies for patients with lung disease due to ABCA3 mutations are nonspecific and ineffective, with the only known definitive treatment option being lung transplant, as was the case for the children homozygous for E690K or W308R ABCA3 mutations profiled in our studies (Figure 1, A and B and Supplemental Figure 1I).